Clinical Trials Directory

Trials / Completed

CompletedNCT03499379

Stress Hormones and IUDs

Effect of Initiation of Intrauterine Contraception on Hair Cortisol Concentration

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

Determine what kind of side effects women experience in the first year after they start using an intrauterine device.

Detailed description

The purpose of this study is to find out if there is a difference in levels of stress hormones in women who use copper or hormonal intrauterine devices (IUDs). This study will provide more information on the potential effect of levonorgestrel intrauterine system (LNG-IUS) use on an individual's stress response. Ultimately, this study hopes to provide data to better counsel women on potential mood effects of the LNG-IUS. From a research and clinical management perspective, hair cortisol may provide a tool to evaluate women at risk for discontinuation of hormonal contraception due to concern of mood symptoms.

Conditions

Interventions

TypeNameDescription
DEVICEMirenaA radio-opaque T-shaped polyethylene device containing 52mg of levonorgestrel dispersed in polydimethylsiloxane on its stem. The progestin is released at a rate of 15 mcg per day.
DEVICEParaguardA T-shaped polyethylene device with 380 mm2 of exposed surface area of fine copper wire wound around its arms and stem. Barium sulfate has been added to the polyethylene frame to make the device radio-opaque. A 3-mm plastic ball is located at the base of the IUD, through which the polyethylene monofilament string passes.

Timeline

Start date
2018-04-16
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-04-17
Last updated
2020-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03499379. Inclusion in this directory is not an endorsement.